Sulfonamide derivative and pharmaceutical use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9822110
APP PUB NO 20160244451A1
SERIAL NO

15142858

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is a sulfonamide derivative represented by the following general formula (1) and having an α4 integrin inhibitory effect with high selectivity with a low effect on α4β1 and a high effect on α4β7, or a pharmaceutically acceptable salt thereof (in the general formula (1), A, B, D, E, R41, and a to h are as described in the description).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EA PHARMA CO LTD2-1-1 IRIFUNE CHUO-KU TOKYO 104-0042

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arisaka, Harumi Kawasaki, JP 6 18
Miyazawa, Tomoko Kawasaki, JP 2 27
Shinkai, Kenji Kawasaki, JP 15 105
Takanohashi, Toshiyuki Kawasaki, JP 12 71
Ueno, Hirokazu Kawasaki, JP 6 48
Yamamoto, Takashi Kawasaki, JP 951 10608

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 21, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 21, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00